Template:Percutaneous Coronary Intervention: Difference between revisions

	Percutaneous Coronary Intervention Guidelines Microchapters
Home
Patient Information
Overview
PCI Approaches:
CAD Revascularization:
Heart Team Approach to Revascularization Decisions
Left Main Coronary Artery Disease
Intervention in left main coronary artery disease
Non-Left Main Coronary Artery Disease
Revascularization to Improve Symptoms
Dual Antiplatelet Therapy Compliance and Stent Thrombosis
Hybrid Coronary Revascularization
Pre-procedural Considerations:
Contrast-Induced Acute Kidney Injury
Anaphylactoid Reactions
Statin Treatment
Bleeding Risk
Role of Onsite Surgical Backup
Procedural Considerations:
Vascular Access
PCI in Specific Clinical Situations:
Asymptomatic Ischemia or CCS Class I or II Angina
CCS Class III Angina
Unstable Angina/Non–ST-Elevation Myocardial Infarction
ST-Elevation Myocardial Infarction:
General and Specific Considerations
Coronary Angiography Strategies in STEMI
Primary PCI of the Infarct Artery
Delayed or Elective PCI in patients with STEMI
Fibrinolytic-Ineligible Patients
Facilitated PCI
Rescue PCI
After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion
Cardiogenic Shock
Prior Coronary Bypass Surgery
Revascularization Before Non-cardiac Surgery
Adjunctive Diagnostic Devices:
Fractional Flow Reserve
Intravascular Ultrasound
Adjunctive Therapeutic Devices:
Coronary Atherectomy
Thrombectomy
Laser Angioplasty
Cutting Balloon Angioplasty
Embolic Protection Devices
Percutaneous Hemodynamic Support Devices
Antiplatelet therapy:
Oral Antiplatelet Therapy
Glycoprotein IIb/IIIa Receptor Antagonists
Intravenous Antiplatelet therapy:
STEMI
UA/NSTEMI
SIHD
Anticoagulant Therapy:
Parenteral Anticoagulants During PCI
Unfractionated Heparin
Enoxaparin
Bivalirudin and Argatroban
Fondaparinux
No-Reflow Pharmacological Therapies
PCI in Specific Anatomic Situations:
Chronic Total Occlusions
Saphenous Vein Grafts
Bifurcation Lesions
Aorto-Ostial Stenoses
Calcified Lesions
PCI in Specific Patient Populations:
Chronic Kidney Disease
Peri-procedural Myocardial Infarction Assessment
Vascular Closure Devices
Post-Procedural Considerations:
Post-procedural Antiplatelet Therapy
Proton Pump Inhibitors and Antiplatelet Therapy
Clopidogrel Genetic Testing
Platelet Function Testing
Restenosis
Exercise Testing
Cardiac Rehabilitation
Quality and Performance Considerations:
Quality and Performance
Certification and Maintenance of Certification
Operator and Institutional Competency and Volume
Percutaneous Coronary Intervention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Percutaneous Coronary Intervention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Percutaneous Coronary Intervention
CDC on Percutaneous Coronary Intervention
Percutaneous Coronary Intervention in the news
Blogs on Percutaneous Coronary Intervention
Directions to Hospitals Treating Percutaneous Coronary Intervention
Risk calculators and risk factors for Percutaneous Coronary Intervention

← Older edit

VisualWikitext

Template:Percutaneous Coronary Intervention: Difference between revisions

Latest revision as of 13:16, 21 June 2022

Navigation menu

@@ Line 3: / Line 3: @@
 | colspan="1" style="text-align:center; background:DarkGray" |
-'''Percutaneous Coronary Intervention Microchapters
+'''Percutaneous Coronary Intervention Guidelines Microchapters
 '''
 |- bgcolor="LightGrey"
@@ Line 10: / Line 10: @@
 |- bgcolor="LightCoral"
 !
-[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines|Home]]
+[[Percutaneous coronary intervention: basic principles and guidelines|Home]]
 |-
 !
@@ Line 16: / Line 16: @@
 |- bgcolor="Pink"
 !
-[[Angioplasty (patient information)|Patient Info]]
+[[Angioplasty (patient information)|Patient Information]]
 |-
 !
+|- bgcolor="Pink"
+!
+[[Percutaneous coronary intervention overview|Overview]]
+|-
+!
 |- bgcolor="CadetBlue"
 !
-Guideline Recommendations
+PCI Approaches:
 |-
 !
+|- bgcolor="CadetBlue"
-|- bgcolor="PaleTurquoise"
 !
 CAD Revascularization:
@@ Line 34: / Line 38: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) heart team approach to revascularization decisions|Heart Team Approach to Revascularization Decisions]]
+::[[Percutaneous coronary intervention heart team approach to revascularization decisions|Heart Team Approach to Revascularization Decisions]]
 |-
 !
@@ Line 40: / Line 44: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) left main coronary artery disease|Left Main Coronary Artery Disease]]
+::[[Percutaneous coronary intervention left main coronary artery disease|Left Main Coronary Artery Disease]]
 |-
 !
@@ Line 46: / Line 50: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) non-left main coronary artery disease|Non-Left Main Coronary Artery Disease]]
+:::[[Intervention in left main coronary artery disease]]
 |-
 !
@@ Line 52: / Line 56: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) revascularization to improve symptoms|Revascularization to Improve Symptoms]]
+::[[Percutaneous coronary intervention non-left main coronary artery disease|Non-Left Main Coronary Artery Disease]]
 |-
 !
@@ Line 58: / Line 62: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) dual antiplatelet therapy compliance and stent thrombosis|Dual Antiplatelet Therapy Compliance and Stent Thrombosis]]
+::[[Percutaneous coronary intervention revascularization to improve symptoms|Revascularization to Improve Symptoms]]
 |-
 !
@@ Line 64: / Line 68: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) hybrid coronary revascularization|Hybrid Coronary Revascularization]]
+::[[Percutaneous coronary intervention dual antiplatelet therapy compliance and stent thrombosis|Dual Antiplatelet Therapy Compliance and Stent Thrombosis]]
 |-
 !
 |- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention hybrid coronary revascularization|Hybrid Coronary Revascularization]]
+|-
+!
+|- bgcolor="CadetBlue"
 !
 Pre-procedural Considerations:
@@ Line 76: / Line 86: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) radiation safety|Radiation Safety]]
+::[[Percutaneous coronary intervention contrast-induced acute kidney injury|Contrast-Induced Acute Kidney Injury]]
 |-
 !
@@ Line 82: / Line 92: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) contrast-induced acute kidney injury|Contrast-Induced Acute Kidney Injury]]
+::[[Percutaneous coronary intervention anaphylactoid reactions|Anaphylactoid Reactions]]
 |-
 !
@@ Line 88: / Line 98: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) anaphylactoid reactions|Anaphylactoid Reactions]]
+::[[Percutaneous coronary intervention statin treatment|Statin Treatment]]
 |-
 !
@@ Line 94: / Line 104: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) statin treatment|Statin Treatment]]
+::[[Percutaneous coronary intervention bleeding risk|Bleeding Risk]]
 |-
 !
@@ Line 100: / Line 110: @@
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) bleeding risk|Bleeding Risk]]
+::[[Percutaneous coronary intervention role of onsite surgical backup|Role of Onsite Surgical Backup]]
 |-
+!
+|- bgcolor="CadetBlue"
+!
+Procedural Considerations:
+|-
 !
 |- bgcolor="PaleTurquoise"
 !
-::[[Percutaneous Coronary Intervention (PCI) role of onsite surgical backup|Role of Onsite Surgical Backup]]
+:[[Percutaneous coronary intervention vascular access|Vascular Access]]
 |-
 !
 |- bgcolor="PaleTurquoise"
 !
-Procedural Considerations:
-:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Vascular Access|Vascular Access]]
 :PCI in Specific Clinical Situations:
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Patients With Asymptomatic Ischemia or CCS Class I or II Angina|PCI in patients with Asymptomatic Ischemia or CCS Class I or II Angina]]
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention asymptomatic ischemia or CCS class I or II angina|Asymptomatic Ischemia or CCS Class I or II Angina]]
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Patients With CCS Class III Angina|PCI in patients with CCS Class III Angina]]
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention CCS class III angina|CCS Class III Angina]]
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in patients with Unstable Angina/Non–ST-Elevation Myocardial Infarction|PCI in patients with Unstable Angina/Non–ST-Elevation Myocardial Infarction]]
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention unstable Angina/non-ST-elevation myocardial infarction|Unstable Angina/Non–ST-Elevation Myocardial Infarction]]
+|-
+!
-::PCI in patients with ST-Elevation Myocardial Infarction:
+|- bgcolor="PaleTurquoise"
+!
+::ST-Elevation Myocardial Infarction:
+|-
+!
-:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Coronary Angiography Strategies in STEMI|Coronary Angiography Strategies in STEMI]]
+|- bgcolor="PaleTurquoise"
+!
+:::[[Percutaneous coronary intervention general and specific considerations|General and Specific Considerations]]
+|-
+!
-:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Primary PCI of the Infarct Artery|Primary PCI of the Infarct Artery]]
+|- bgcolor="PaleTurquoise"
+!
+:::[[Percutaneous coronary intervention coronary angiography strategies in STEMI|Coronary Angiography Strategies in STEMI]]
+|-
+!
-:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Delayed or Elective PCI in Patients with STEMI|Delayed or Elective PCI in patients with STEMI]]
+|- bgcolor="PaleTurquoise"
+!
+:::[[Percutaneous coronary intervention primary PCI of the infarct artery|Primary PCI of the Infarct Artery]]
+|-
+!
-:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Patients With STEMI: General and Specific Considerations|STEMI: General and Specific Considerations]]
+|- bgcolor="PaleTurquoise"
+!
+:::[[Percutaneous coronary intervention delayed or elective PCI in patients with STEMI|Delayed or Elective PCI in patients with STEMI]]
+|-
+!
-:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in Fibrinolytic-Ineligible Patients|PCI in Fibrinolytic-Ineligible Patients]]
+|- bgcolor="PaleTurquoise"
+!
+:::[[Percutaneous coronary intervention fibrinolytic-ineligible patients|Fibrinolytic-Ineligible Patients]]
+|-
+!
-:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Facilitated PCI|Facilitated PCI]]
+|- bgcolor="PaleTurquoise"
+!
+:::[[Percutaneous coronary intervention facilitated PCI|Facilitated PCI]]
+|-
+!
-:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Rescue PCI (PCI After Failed Fibrinolysis)|Rescue PCI]]
+|- bgcolor="PaleTurquoise"
+!
+:::[[Percutaneous coronary intervention rescue PCI (PCI after failed fibrinolysis)|Rescue PCI]]
+|-
+!
-:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion|PCI After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion]]
+|- bgcolor="PaleTurquoise"
+!
+:::[[Percutaneous coronary intervention after successful fibrinolysis or for patients not undergoing primary reperfusion|After Successful Fibrinolysis or for Patients Not Undergoing Primary Reperfusion]]
+|-
+!
-:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in patients with Cardiogenic Shock|PCI in patients with Cardiogenic Shock]]
+|- bgcolor="PaleTurquoise"
+!
+:[[Percutaneous coronary intervention Cardiogenic shock|Cardiogenic Shock]]
+|-
+!
-:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#PCI in patients with Prior Coronary Bypass Surgery|PCI in patients with Prior Coronary Bypass Surgery]]
+|- bgcolor="PaleTurquoise"
+!
+:[[Percutaneous coronary intervention prior coronary bypass surgery|Prior Coronary Bypass Surgery]]
+|-
+!
-:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Revascularization Before Non-cardiac Surgery|Revascularization Before Non-cardiac Surgery]]
+|- bgcolor="PaleTurquoise"
+!
-:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Coronary Stents|Coronary Stents]]
+:[[Percutaneous coronary intervention revascularization before non-cardiac surgery|Revascularization Before Non-cardiac Surgery]]
+|-
+!
+|- bgcolor="PaleTurquoise"
+!
 :Adjunctive Diagnostic Devices:
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Fractional Flow Reserve|Fractional Flow Reserve]]
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention fractional flow reserve|Fractional Flow Reserve]]
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Intravascular Ultrasound|Intravascular Ultrasound]]
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention intravascular ultrasound|Intravascular Ultrasound]]
+|-
+!
+|- bgcolor="PaleTurquoise"
+!
 :Adjunctive Therapeutic Devices:
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Coronary Atherectomy|Coronary Atherectomy]]
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention coronary atherectomy|Coronary Atherectomy]]
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Thrombectomy|Thrombectomy]]
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention thrombectomy|Thrombectomy]]
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Laser Angioplasty|Laser Angioplasty]]
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention laser angioplasty|Laser Angioplasty]]
+|-
+!
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention cutting balloon angioplasty|Cutting Balloon Angioplasty]]
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Cutting Balloon Angioplasty|Cutting Balloon Angioplasty]]
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention embolic protection devices|Embolic Protection Devices]]
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Embolic Protection Devices|Embolic Protection Devices]]
+|- bgcolor="PaleTurquoise"
+!
+:[[Percutaneous coronary intervention percutaneous hemodynamic support devices|Percutaneous Hemodynamic Support Devices]]
+|-
+!
-:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Percutaneous Hemodynamic Support Devices|Percutaneous Hemodynamic Support Devices]]
+|- bgcolor="PaleTurquoise"
+!
+:Antiplatelet therapy:
+|-
+!
-:Antiplatelet Therapy:
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention oral antiplatelet therapy|Oral Antiplatelet Therapy]]
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Oral Antiplatelet Therapy|Oral Antiplatelet Therapy]]
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention Glycoprotein IIb/IIIa Receptor Antagonists|Glycoprotein IIb/IIIa Receptor Antagonists]]
+|-
+!
-::Intravenous Antiplatelet Therapy:
+|- bgcolor="PaleTurquoise"
+!
+::Intravenous Antiplatelet therapy:
+|-
+!
-:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Intravenous Antiplatelet Therapy: ST-Elevation Myocardial Infarction (STEMI)|STEMI]]
+|- bgcolor="PaleTurquoise"
+!
+::::[[Percutaneous coronary intervention ST-elevation myocardial infarction (STEMI)|STEMI]]
+|-
+!
-:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Intravenous Antiplatelet Therapy: Unstable Angina / Non-ST Elevation Myocardial Infarction (UA/NSTEMI)|UA/NSTEMI]]
+|- bgcolor="PaleTurquoise"
+!
+::::[[Percutaneous coronary intervention unstable angina / non-ST elevation myocardial infarction (UA/NSTEMI)|UA/NSTEMI]]
+|-
+!
-:::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Intravenous Antiplatelet Therapy: Sudden Ischemia Heart Disease (SIHD)|SIHD]]
+|- bgcolor="PaleTurquoise"
+!
+::::[[Percutaneous coronary intervention sudden ischemia heart disease (SIHD)|SIHD]]
+|-
+!
+|- bgcolor="PaleTurquoise"
+!
 :Anticoagulant Therapy:
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Use of Parenteral Anticoagulants during PCI|Parenteral Anticoagulants During PCI]]
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention use of parenteral anticoagulants during PCI|Parenteral Anticoagulants During PCI]]
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Unfractionated Heparin|Unfractionated Heparin]]
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention unfractionated heparin|Unfractionated Heparin]]
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Enoxaparin|Enoxaparin]]
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention enoxaparin|Enoxaparin]]
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Bivalirudin and Argatoban|Bivalirudin and Argatroban]]
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention bivalirudin and argatoban|Bivalirudin and Argatroban]]
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Fondaparinux|Fondaparinux]]
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention fondaparinux|Fondaparinux]]
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#No-Reflow Pharmacological Therapies|No-Reflow Pharmacological Therapies]]
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention no-reflow pharmacological therapies|No-Reflow Pharmacological Therapies]]
+|-
+!
+|- bgcolor="PaleTurquoise"
+!
 :PCI in Specific Anatomic Situations:
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Chronic Total Occlusions|Chronic Total Occlusions]]
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention chronic total occlusions|Chronic Total Occlusions]]
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Saphenous Vein Grafts|Saphenous Vein Grafts]]
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention saphenous vein grafts|Saphenous Vein Grafts]]
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Bifurcation Lesions|Bifurcation Lesions]]
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention bifurcation lesions|Bifurcation Lesions]]
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Aorto-Ostial Stenoses|Aorto-Ostial Stenoses]]
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention aorto-ostial stenoses|Aorto-Ostial Stenoses]]
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Calcified Lesions|Calcified Lesions]]
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention calcified lesions|Calcified Lesions]]
+|-
+!
+|- bgcolor="PaleTurquoise"
+!
 :PCI in Specific Patient Populations:
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Chronic Kidney Disease|Chronic Kidney Disease]]
+|- bgcolor="PaleTurquoise"
+!
+::[[Percutaneous coronary intervention chronic kidney disease|Chronic Kidney Disease]]
+|-
+!
-:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Peri-procedural Myocardial Infarction Assessment|Peri-procedural Myocardial Infarction Assessment]]
+|- bgcolor="PaleTurquoise"
+!
+:[[Percutaneous coronary intervention peri-procedural myocardial infarction assessment|Peri-procedural Myocardial Infarction Assessment]]
+|-
+!
-:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Vascular Closure Devices|Vascular Closure Devices]]
+|- bgcolor="PaleTurquoise"
-|-
+!
-!
+:[[Percutaneous coronary intervention vascular closure devices|Vascular Closure Devices]]
+|-
+!
-|- bgcolor="PaleTurquoise"
+|- bgcolor="CadetBlue"
 !
 Post-Procedural Considerations:
+|-
+!
-:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Post-procedural Antiplatelet Therapy|Post-procedural Antiplatelet Therapy:]]
+|- bgcolor="PaleTurquoise"
+!
+:[[Percutaneous coronary intervention post-procedural antiplatelet therapy|Post-procedural Antiplatelet Therapy]]
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Proton Pump Inhibitors and Anti-platelet Therapy|Proton Pump Inhibitors and Antiplatelet Therapy]]
+|- bgcolor="PaleTurquoise"
+!
+:[[Percutaneous coronary intervention proton pump inhibitors and anti-platelet therapy|Proton Pump Inhibitors and Antiplatelet Therapy]]
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Clopidogrel Genetic Testing|Clopidogrel Genetic Testing]]
+|- bgcolor="PaleTurquoise"
+!
+:[[Percutaneous coronary intervention clopidogrel genetic testing|Clopidogrel Genetic Testing]]
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Platelet Function Testing|Platelet Function Testing]]
+|- bgcolor="PaleTurquoise"
+!
+:[[Percutaneous coronary intervention platelet function testing|Platelet Function Testing]]
+|-
+!
-:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Restenosis|Restenosis:]]
+|- bgcolor="PaleTurquoise"
+!
+:[[Percutaneous coronary intervention restenosis|Restenosis]]
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Exercise Testing|Exercise Testing]]
+|- bgcolor="PaleTurquoise"
+!
+:[[Percutaneous coronary intervention exercise testing|Exercise Testing]]
+|-
+!
-::[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Cardiac Rehabilitation|Cardiac Rehabilitation]]
+|- bgcolor="PaleTurquoise"
-|-
+!
-!
+:[[Percutaneous coronary intervention cardiac rehabilitation|Cardiac Rehabilitation]]
+|-
+!
-|- bgcolor="PaleTurquoise"
+|- bgcolor="CadetBlue"
 !
 Quality and Performance Considerations:
+|-
+!
-:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Quality and Performance|Quality and Performance]]
+|- bgcolor="PaleTurquoise"
+!
+:[[Percutaneous coronary intervention quality and performance|Quality and Performance]]
+|-
+!
-:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Certification and Maintenance of Certification|Certification and Maintenance of Certification]]
+|- bgcolor="PaleTurquoise"
+!
+:[[Percutaneous coronary intervention certification and maintenance of certification|Certification and Maintenance of Certification]]
+|-
+!
-:[[Percutaneous Coronary Intervention (PCI): Basic Principles and Guidelines#Operator and Institutional Competency and Volume|Operator and Institutional Competency and Volume]]
+|- bgcolor="PaleTurquoise"
-|-
+!
-!
+:[[Percutaneous coronary intervention operator and institutional competency and volume|Operator and Institutional Competency and Volume]]
+|-
+!
 |- bgcolor="PaleGoldenrod "

Template:Percutaneous Coronary Intervention: Difference between revisions

Latest revision as of 13:16, 21 June 2022

Navigation menu

Search